Traumatic Brain Injury (TBI)
- Cannabidiol, a nonpsychoactive Cannabis constituent, protects against myocardial ischemic reperfusion injury
- Cannabidiol prevents infarction via the non-CB1 cannabinoid receptor mechanism
- Cannabidiol prevents cerebral infarction via a serotonergic 5-hydroxytryptamine1A receptor-dependent mechanism
- Cannabidiol administration after hypoxia-ischemia to newborn rats reduces long-term brain injury and restores neurobehavioral function
- Protective Effects of Cannabidiol Against Hippocampal Cell Death and Cognitive Impairment Induced by Bilateral Common Carotid Artery Occlusion in Mice
- Repeated treatment with cannabidiol but not Delta9-tetrahydrocannabinol has a neuroprotective effect without the development of tolerance
- CBD reduces brain damage and improves functional recovery in a neonatal rat model of arterial ischemic stroke
- Acute upregulation of neuronal mitochondrial type-1 cannabinoid receptor and it’s role in metabolic defects and neuronal apoptosis after TBI
- An endogenous cannabinoid (2-AG) is neuroprotective after brain injury
- Cannabinoid agonist rescues learning and memory after a traumatic brain injury
- Early increase of cannabinoid receptor density after experimental traumatic brain injury in the newborn piglet
- Endocannabinoids and traumatic brain injury
- Preclinical evaluation of SMM-189, a cannabinoid receptor 2-specific inverse agonist